Qasim Khalid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qasim Khalid has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Junad Khan
University of Rochester
4 shared publications - Umar Hussain
Orthodontics, Saidu College of Dentistry, Swat, Pakistan
3 shared publications - Waqas Naseem
Department of Health Sciences University of Debrecen Debrecen Hungary
3 shared publications - Alessandra Campobasso
Orthodontics, Melbourne Dental School, Faculty of Medicine, Dentistry and Health Sciences University of Melbourne Melbourne Victoria Australia
2 shared publications - Farhana Umer
CMH Medical College and Institute of Dentistry, Lahore, Pakistan
2 shared publications - Hamna Omair
PGR, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan
2 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12 (5) , e70473
Topical Anesthetics Effectiveness in Management of Orthodontic Pain: A Systematic Review of Randomized Controlled Trials
Objectives: Orthodontic treatment can be associated with pain, particularly during separator placement, appliance insertion, or activation. Topical anesthetics may offer a simple, locally applied alternative to systemic analgesics, but their effectiveness remains uncertain. The objective of this review was to evaluate the efficacy of topical anesthetics, compared to other treatments or no treatment, in reducing orthodontic pain. Material and Methods: Eligible studies were randomized controlled trials (RCTs) comparing topical anesthetics (gels or patches) with placebo, no treatment, or other active pain‐control interventions in orthodontic patients. Five databases (PubMed, Scopus, Cochrane CENTRAL, Embase, Web of Science) were searched up to 14th March 2026, with no language or date restrictions. Data were extracted in duplicate, and the risk of bias was assessed using the ROB‐2 tool. Due to heterogeneity, only a qualitative synthesis was performed. Results: Nine RCTs (456 participants, mean age 14–35 years; 36.3% male) conducted in four countries were included. Benzocaine was the most investigated, followed by lidocaine, prilocaine/lidocaine, and menthol. Most studies examined separator‐induced pain. Eight of nine trials reported significant reductions in pain intensity with topical anesthetics at one or more time points, particularly within the first 24 to 72 h. Benzocaine consistently showed superior outcomes compared with placebo. Lidocaine and prilocaine/lidocaine provided rapid analgesia, especially in patients with high anxiety or low pain thresholds. Menthol patches also showed significant short‐term pain reduction in two studies. Risk of bias was moderate in most trials. Conclusion: Topical anesthetics can be effective in reducing short‐term orthodontic pain. Their use may reduce reliance on systemic analgesics and improve patient comfort during the initial stages of treatment. However, evidence quality remains limited, and further high‐quality RCTs with standardized protocols are needed.
- 6 October 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12 (5) , e70473
Open AccessTopical Anesthetics Effectiveness in Management of Orthodontic Pain: A Systematic Review of Randomized Controlled Trials
Objectives: Orthodontic treatment can be associated with pain, particularly during separator placement, appliance insertion, or activation. Topical anesthetics may offer a simple, locally applied alternative to systemic analgesics, but their effectiveness remains uncertain. The objective of this review was to evaluate the efficacy of topical anesthetics, compared to other treatments or no treatment, in reducing orthodontic pain. Material and Methods: Eligible studies were randomized controlled trials (RCTs) comparing topical anesthetics (gels or patches) with placebo, no treatment, or other active pain‐control interventions in orthodontic patients. Five databases (PubMed, Scopus, Cochrane CENTRAL, Embase, Web of Science) were searched up to 14th March 2026, with no language or date restrictions. Data were extracted in duplicate, and the risk of bias was assessed using the ROB‐2 tool. Due to heterogeneity, only a qualitative synthesis was performed. Results: Nine RCTs (456 participants, mean age 14–35 years; 36.3% male) conducted in four countries were included. Benzocaine was the most investigated, followed by lidocaine, prilocaine/lidocaine, and menthol. Most studies examined separator‐induced pain. Eight of nine trials reported significant reductions in pain intensity with topical anesthetics at one or more time points, particularly within the first 24 to 72 h. Benzocaine consistently showed superior outcomes compared with placebo. Lidocaine and prilocaine/lidocaine provided rapid analgesia, especially in patients with high anxiety or low pain thresholds. Menthol patches also showed significant short‐term pain reduction in two studies. Risk of bias was moderate in most trials. Conclusion: Topical anesthetics can be effective in reducing short‐term orthodontic pain. Their use may reduce reliance on systemic analgesics and improve patient comfort during the initial stages of treatment. However, evidence quality remains limited, and further high‐quality RCTs with standardized protocols are needed.
- Open Access
- 1 April 2026
- Vol. 12 (2) , e70321
Effect of Self-Assembling Peptide on White Spot Lesions in Orthodontic Patients: A Systematic Review and Meta-Analysis.
Objective: To evaluate the effect of self-assembling peptide (SAP) on white spot lesions (WSLs) in orthodontic patients with fixed appliances. Eligibility Criteria: Randomized and non-randomized clinical studies, as well as in vitro studies, comparing SAP with fluoride or no treatment for WSLs in orthodontic patients were included. Outcomes assessed were WSL score, lesion size, or fluorescence loss. Case reports, case series, animal studies, and narrative reviews were excluded. Comprehensive literature search of six databases was conducted up to May 16, 2025. Risk of Bias: Risk of bias was assessed using tools appropriate to each study design: RoB-2 for randomized controlled trials, ROBINS-I for non-randomized studies, and QUIN for in vitro studies. Random effects meta- analyses using standardized mean differences (SMDs) and their 95% confidence intervals (CIs) were performed, followed by subgroup, sensitivity analyses, and assessment of the quality of evidence was done using GRADE approach. Included Studies: Eight studies (five randomized, two non-randomized prospective, one in vitro) involving 395 participants were included. Meta-analysis of eight studies showed a significant reduction in severity of WSLs with SAP compared to fluoride or control (SMD = -1.68; 95% CI: -2.71 to -0.67; p = 0.005), but with high heterogeneity (I2 = 85.4%) and wide prediction interval (-4.20 to 0.82). Evidence certainty was very low due to risk of bias, inconsistency, imprecision, and indirectness. Limitations of Evidence: The study is limited by the inclusion of less number of studies, one in-vitro study, and some non-randomized trials. It can be concluded that very low-level evidence is available that SAP can reduce the severity of WSLs associated with fixed orthodontic treatment more effectively than topical fluoride or no treatment. PROPSERO Registration Number: (CRD420251112657).
- 1 April 2026
- Vol. 12 (2) , e70321
Open AccessEffect of Self-Assembling Peptide on White Spot Lesions in Orthodontic Patients: A Systematic Review and Meta-Analysis.
Objective: To evaluate the effect of self-assembling peptide (SAP) on white spot lesions (WSLs) in orthodontic patients with fixed appliances. Eligibility Criteria: Randomized and non-randomized clinical studies, as well as in vitro studies, comparing SAP with fluoride or no treatment for WSLs in orthodontic patients were included. Outcomes assessed were WSL score, lesion size, or fluorescence loss. Case reports, case series, animal studies, and narrative reviews were excluded. Comprehensive literature search of six databases was conducted up to May 16, 2025. Risk of Bias: Risk of bias was assessed using tools appropriate to each study design: RoB-2 for randomized controlled trials, ROBINS-I for non-randomized studies, and QUIN for in vitro studies. Random effects meta- analyses using standardized mean differences (SMDs) and their 95% confidence intervals (CIs) were performed, followed by subgroup, sensitivity analyses, and assessment of the quality of evidence was done using GRADE approach. Included Studies: Eight studies (five randomized, two non-randomized prospective, one in vitro) involving 395 participants were included. Meta-analysis of eight studies showed a significant reduction in severity of WSLs with SAP compared to fluoride or control (SMD = -1.68; 95% CI: -2.71 to -0.67; p = 0.005), but with high heterogeneity (I2 = 85.4%) and wide prediction interval (-4.20 to 0.82). Evidence certainty was very low due to risk of bias, inconsistency, imprecision, and indirectness. Limitations of Evidence: The study is limited by the inclusion of less number of studies, one in-vitro study, and some non-randomized trials. It can be concluded that very low-level evidence is available that SAP can reduce the severity of WSLs associated with fixed orthodontic treatment more effectively than topical fluoride or no treatment. PROPSERO Registration Number: (CRD420251112657).
- Open Access
- 26 February 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12 (2)
Effect of Self‐Assembling Peptide on White Spot Lesions in Orthodontic Patients: A Systematic Review and Meta‐Analysis
Background: Objective : To evaluate the effect of self‐assembling peptide (SAP) on white spot lesions (WSLs) in orthodontic patients with fixed appliances. Methods: Eligibility Criteria : Randomized and non‐randomized clinical studies, as well as in vitro studies, comparing SAP with fluoride or no treatment for WSLs in orthodontic patients were included. Outcomes assessed were WSL score, lesion size, or fluorescence loss. Case reports, case series, animal studies, and narrative reviews were excluded. Information Sources: Comprehensive literature search of six databases was conducted up to May 16, 2025. Risk of Bias : Risk of bias was assessed using tools appropriate to each study design: RoB‐2 for randomized controlled trials, ROBINS‐I for non‐randomized studies, and QUIN for in vitro studies. Synthesis of Results: Random effects meta‐ analyses using standardized mean differences (SMDs) and their 95% confidence intervals (CIs) were performed, followed by subgroup, sensitivity analyses, and assessment of the quality of evidence was done using GRADE approach. Results: Included Studies : Eight studies (five randomized, two non‐randomized prospective, one in vitro) involving 395 participants were included. Synthesis of Results: Meta‐analysis of eight studies showed a significant reduction in severity of WSLs with SAP compared to fluoride or control (SMD = −1.68; 95% CI: −2.71 to −0.67; p = 0.005), but with high heterogeneity ( I 2 = 85.4%) and wide prediction interval (−4.20 to 0.82). Evidence certainty was very low due to risk of bias, inconsistency, imprecision, and indirectness. Discussion: Limitations of Evidence: The study is limited by the inclusion of less number of studies, one in‐vitro study, and some non‐randomized trials. Interpretation/Conclusion : It can be concluded that very low‐level evidence is available that SAP can reduce the severity of WSLs associated with fixed orthodontic treatment more effectively than topical fluoride or no treatment. Registration : PROPSERO Registration Number: (CRD420251112657).
- 26 February 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12 (2)
Open AccessEffect of Self‐Assembling Peptide on White Spot Lesions in Orthodontic Patients: A Systematic Review and Meta‐Analysis
Background: Objective : To evaluate the effect of self‐assembling peptide (SAP) on white spot lesions (WSLs) in orthodontic patients with fixed appliances. Methods: Eligibility Criteria : Randomized and non‐randomized clinical studies, as well as in vitro studies, comparing SAP with fluoride or no treatment for WSLs in orthodontic patients were included. Outcomes assessed were WSL score, lesion size, or fluorescence loss. Case reports, case series, animal studies, and narrative reviews were excluded. Information Sources: Comprehensive literature search of six databases was conducted up to May 16, 2025. Risk of Bias : Risk of bias was assessed using tools appropriate to each study design: RoB‐2 for randomized controlled trials, ROBINS‐I for non‐randomized studies, and QUIN for in vitro studies. Synthesis of Results: Random effects meta‐ analyses using standardized mean differences (SMDs) and their 95% confidence intervals (CIs) were performed, followed by subgroup, sensitivity analyses, and assessment of the quality of evidence was done using GRADE approach. Results: Included Studies : Eight studies (five randomized, two non‐randomized prospective, one in vitro) involving 395 participants were included. Synthesis of Results: Meta‐analysis of eight studies showed a significant reduction in severity of WSLs with SAP compared to fluoride or control (SMD = −1.68; 95% CI: −2.71 to −0.67; p = 0.005), but with high heterogeneity ( I 2 = 85.4%) and wide prediction interval (−4.20 to 0.82). Evidence certainty was very low due to risk of bias, inconsistency, imprecision, and indirectness. Discussion: Limitations of Evidence: The study is limited by the inclusion of less number of studies, one in‐vitro study, and some non‐randomized trials. Interpretation/Conclusion : It can be concluded that very low‐level evidence is available that SAP can reduce the severity of WSLs associated with fixed orthodontic treatment more effectively than topical fluoride or no treatment. Registration : PROPSERO Registration Number: (CRD420251112657).